How Likely is a Second wave?

7 September 2020. Updated 8 September 2020. Paul Kirkham, Professor of cell Biology and Head of Respiratory Disease Research Group at Wolverhampton University Dr Mike Yeadon, former CSO and VP, Allergy and Respiratory Research Head with Pfizer Global R&D and co-Founder of Ziarco Pharma Ltd Barry Thomas, Epidemiologist Contents Executive SummaryBackgroundMortality and critical careA complete … Continue reading How Likely is a Second wave?